As per the research report, the size of the Europe Adhesion Barrier Market was valued at USD 268.58 million in 2021 and estimated to be growing at a CAGR of 8.2%, to reach USD 398.31 million by 2026.
The European adhesion barrier market is growing with the increasing number of surgical procedures. It is estimated that the growing awareness of the use of adhesion barriers after surgery in developing countries will drive the demand for adhesion barriers and hence contribute to the growth rate of the market during the forecast period.
The demand for adhesion barrier is growing due to the increasing growth of chronic diseases, the increase in the elderly population and the increasing number of surgeries performed among the aging population. The emergence of companies focused on the R&D of adhesion barriers and the launch of new products and devices on the market are further accelerating the European market. In addition, it is believed that the growing awareness of the use of Adhesion Barriers after surgery in developing countries will drive the demand for Adhesion Barriers and hence contribute to the growth of Adhesion Barriers market during the period of forecast 2020-2025.
However, the risk of using adhesion barriers in patients with a history of hypersensitivity and the choice to use adhesion barriers among surgeons have been significant factors hampering the growth of the market. The market still faces barriers in terms of accessibility, lack of health education and lack of awareness of the importance of treatment.
Abdominal surgery is one of the most common causes of adhesions; it is estimated that about 75-85% of all adhesions are attributed to abdominal surgery. Most laparoscopic procedures cause adhesions. In Europe, 500,100 laparoscopic surgeries are performed each year. These factors are expected to have a positive impact on the growth of the market.
Regulatory requirements for medical device registration are complex and change with changing needs. These regulations are complicated, mainly because of the legal aspects associated with them. The quality and performance of adhesion barriers are necessary aspects that require rigorous evaluation to ensure public safety. Complex and strict standards are followed for the enrollment of medical devices. Strict regulatory requirements are challenging the growth of the Adhesion Barriers market for the forecast period (2020-2025). However, the limited applications of certain types of adhesion barrier products and the high cost of surgeries are expected to hamper the growth of the adhesion barriers market.
This research report on the Europe Adhesion Barrier Market has been segmented and sub-segmented into the following categories:
By Product Form:
By Surgical Application:
Europe is expected to represent the second largest share of the global adhesion barriers market due to the increasing use of advanced adhesion barriers and increasing product development by existing manufacturers.
The UK adhesion barriers market held the dominant share in the European region in terms of revenue in 2019 due to the developed medical infrastructure and favorable reimbursements for membership barriers.
Germany is expected to outperform all regions with the highest CAGR during the forecast period 2020-2025 due to the increase in the geriatric population and the increased incidence of cardiac surgery and neurosurgery that requires surgical procedures. In addition, growing private sector investments in healthcare and rapidly expanding medical tourism are expected to boost the market in the region.
Key players operating in the Europe Adhesion Barrier Market profiled in this report are Baxter International Inc., Medtronic Plc., C. R. Bard, Inc., Johnson & Johnson, Sanofi Group, Atrium Medical Corporation, Integra Lifesciences Corporation, Anika Therapeutics Inc., FzioMed, Inc., and MAST Biosurgery AG.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.2 Synthetic Adhesion Barriers
126.96.36.199 Regenerated Cellulose
188.8.131.52 Hyaluronic Acid
184.108.40.206 Polythene Glycol
5.1.3 Natural Adhesion Barriers
220.127.116.11 Collagen & Protein
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Product Form
5.2.2 Film Adhesion Barriers
5.2.3 Gel Adhesion Barriers
5.2.4 Liquid Adhesion Barriers
5.2.5 Y-o-Y Growth Analysis, By Product Form
5.2.6 Market Attractiveness Analysis, By Product Form
5.2.7 Market Share Analysis, By Product Form
5.3 Surgical Applications
5.3.2 Gynaecological Surgeries
5.3.3 Cardiovascular Surgeries
5.3.4 Neurological Surgeries
5.3.5 Orthopaedic Surgeries
5.3.6 General/Abdominal Surgeries
5.3.7 Urological Surgeries
5.3.8 Reconstructive Surgeries
5.3.9 Other Surgeries
5.3.10 Y-o-Y Growth Analysis, By Surgical Applications
5.3.11 Market Attractiveness Analysis, By Surgical Applications
5.3.12 Market Share Analysis, By Surgical Applications
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
18.104.22.168 By Geographical Area
22.214.171.124 By Product
126.96.36.199 By Product Form
188.8.131.52 By Surgical Applications
6.1.4 Market Attractiveness Analysis
184.108.40.206 By Geographical Area
220.127.116.11 By Product
18.104.22.168 By Product Form
22.214.171.124 By Surgical Applications
6.1.5 Market Share Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Product
184.108.40.206 By Product Form
220.127.116.11 By Surgical Applications
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Baxter International Inc.
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Medtronic Plc.
8.3 C. R. Bard, Inc.
8.4 Johnson & Johnson
8.5 Sanofi Group
8.6 Atrium Medical Corporation
8.7 Integra Lifesciences Corporation
8.8 Anika Therapeutics Inc.
8.9 FzioMed, Inc.
8.10 MAST Biosurgery AG
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures